Aurélien L.
- Country
- France
- Department
- Service d'Hématologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 44 partner sites.
Specializations
Hemophilia Research
The investigator specializes in the treatment of hemophilia A and B, with particular emphasis on patients who have developed inhibitors. Their research encompasses innovative therapeutic approaches for managing bleeding disorders.
- Prophylactic Treatment Evaluation
- Bleeding Episode Management
- Joint Health Assessment
The investigator's work includes monitoring joint outcomes through advanced imaging techniques like ultrasound in hemophilia patients.
Coagulation Medicine
The investigator focuses on evaluating novel coagulation factor treatments, including research with bypassing agents and extended half-life products for bleeding disorder management.
- Factor Replacement Therapy
- Prophylactic Treatment Strategies
- Inhibitor Management
Their expertise extends to studying advanced coagulation therapeutics such as efmoroctocog alfa and eftrenonacog alfa.
Clinical Outcomes
The investigator's research emphasizes long-term patient outcomes in bleeding disorders, with particular attention to prophylactic treatment efficacy and joint health preservation.
- Treatment Efficacy Assessment
- Longitudinal Monitoring
- Comparative Treatment Studies
Their work involves evaluating the effectiveness of various therapeutic approaches through systematic clinical assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.